DAE HWA Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,357	1,658	4,350	3,125	4,002
Short-Term Investments	3,300	5,100	7,620	3,240	11,340
Trading Asset Securities	1,445	1,104	1,489	1,597	3,080
Cash & Short-Term Investments	6,102	7,863	13,458	7,962	18,422
Cash Growth	-22.39%	-41.58%	69.03%	-56.78%	49.05%
Accounts Receivable	19,306	20,383	22,755	18,137	16,719
Other Receivables	966.01	1,006	1,422	1,313	1,517
Receivables	20,272	21,389	24,176	19,450	18,236
Inventory	35,183	31,340	26,678	23,413	18,682
Prepaid Expenses	669.01	480.34	310.27	294.59	287.91
Other Current Assets	132.6	534.76	597.23	92.92	511.03
Total Current Assets	62,359	61,607	65,220	51,213	56,139
Property, Plant & Equipment	88,847	91,702	94,351	89,857	68,245
Long-Term Investments	4,869	3,798	10,929	10,475	8,639
Goodwill	693.16	693.16	693.16	693.16	693.16
Other Intangible Assets	29,608	28,630	27,822	26,972	23,775
Long-Term Deferred Tax Assets	4,580	3,622	3,992	3,642	4,172
Other Long-Term Assets	19,908	15,831	16,154	16,204	15,713
Total Assets	210,863	205,884	219,163	199,056	177,376
Accounts Payable	13,588	11,597	15,783	12,925	8,026
Accrued Expenses	2,659	2,559	2,669	2,958	1,504
Short-Term Debt	61,628	59,199	74,457	59,055	56,347
Current Portion of Long-Term Debt	31,195	34,238	28,189	3,250	2,500
Current Portion of Leases	122.61	117.78	149.65	201.76	238.02
Current Income Taxes Payable	231.2	46.26	27.35	380.05	1,463
Current Unearned Revenue	42.35	42.35	42.35	50.19	69.05
Other Current Liabilities	12,019	9,893	6,631	4,440	5,189
Total Current Liabilities	121,484	117,693	127,948	83,260	75,335
Long-Term Debt	3,690	5,566	7,500	27,307	10,796
Long-Term Leases	139.96	151.94	229.92	251.93	269.24
Pension & Post-Retirement Benefits	3,726	3,770	3,676	3,275	4,402
Other Long-Term Liabilities	2,682	2,334	2,457	3,271	3,157
Total Liabilities	131,722	129,515	141,809	117,365	93,960
Common Stock	9,308	9,308	9,308	9,308	9,308
Additional Paid-In Capital	35,556	33,023	33,023	33,023	33,023
Retained Earnings	38,319	39,383	41,562	45,862	46,529
Treasury Stock	-7,573	-9,162	-9,162	-9,162	-9,162
Comprehensive Income & Other	-1,537	-554.04	-1,500	-1,040	-24.6
Total Common Equity	74,073	71,999	73,232	77,993	79,674
Minority Interest	5,069	4,371	4,121	3,699	3,742
Shareholders' Equity	79,142	76,370	77,353	81,691	83,416
Total Liabilities & Equity	210,863	205,884	219,163	199,056	177,376
Total Debt	96,776	99,274	110,525	90,066	70,150
Net Cash (Debt)	-90,674	-91,411	-97,067	-82,104	-51,728
Net Cash Per Share	-5154.69	-5160.42	-5541.39	-4687.19	-2962.69
Filing Date Shares Outstanding	17.81	17.52	17.52	17.52	17.52
Total Common Shares Outstanding	17.81	17.52	17.52	17.52	17.52
Working Capital	-59,125	-56,085	-62,728	-32,047	-19,196
Book Value Per Share	4158.56	4110.33	4180.70	4452.48	4548.48
Tangible Book Value	43,771	42,676	44,717	50,327	55,206
Tangible Book Value Per Share	2457.38	2436.30	2552.81	2873.10	3151.65
Land	15,659	18,964	19,097	19,097	19,097
Buildings	66,865	67,440	67,144	45,065	45,065
Machinery	69,554	62,371	56,983	42,936	44,633
Construction In Progress	847.17	470.04	2,765	29,549	3,035

Source: S&P Global Market Intelligence. Standard template. Financial Sources.